Literature DB >> 7832431

Bromocriptine scavenges methamphetamine-induced hydroxyl radicals and attenuates dopamine depletion in mouse striatum.

T Kondo1, T Ito, Y Sugita.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7832431     DOI: 10.1111/j.1749-6632.1994.tb21807.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


× No keyword cloud information.
  12 in total

Review 1.  Are dopamine receptor agonists neuroprotective in Parkinson's disease?

Authors:  W D Le; J Jankovic
Journal:  Drugs Aging       Date:  2001       Impact factor: 3.923

2.  Mitochondria-targeted antioxidant effects of S(-) and R(+) pramipexole.

Authors:  Giulia Ferrari-Toninelli; Giuseppina Maccarinelli; Daniela Uberti; Erich Buerger; Maurizio Memo
Journal:  BMC Pharmacol       Date:  2010-02-05

Review 3.  Neuroprotective strategies in Parkinson's disease : an update on progress.

Authors:  Silvia Mandel; Edna Grünblatt; Peter Riederer; Manfred Gerlach; Yona Levites; Moussa B H Youdim
Journal:  CNS Drugs       Date:  2003       Impact factor: 5.749

4.  Lack of increased oxidative stress in catechol-O-methyltransferase (COMT)-deficient mice.

Authors:  Markus M Forsberg; Risto O Juvonen; Petra Helisalmi; Jukka Leppänen; Joseph A Gogos; Maria Karayiorgou; Pekka T Männistö
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2004-09-17       Impact factor: 3.000

Review 5.  Interactions of HIV and methamphetamine: cellular and molecular mechanisms of toxicity potentiation.

Authors:  J L Cadet; I N Krasnova
Journal:  Neurotox Res       Date:  2007-10       Impact factor: 3.911

Review 6.  Molecular bases of methamphetamine-induced neurodegeneration.

Authors:  Jean Lud Cadet; Irina N Krasnova
Journal:  Int Rev Neurobiol       Date:  2009       Impact factor: 3.230

Review 7.  Methamphetamine toxicity and messengers of death.

Authors:  Irina N Krasnova; Jean Lud Cadet
Journal:  Brain Res Rev       Date:  2009-03-25

Review 8.  Neurotoxicity of substituted amphetamines: molecular and cellular mechanisms.

Authors:  Jean Lud Cadet; Irina N Krasnova; Subramaniam Jayanthi; Johnalyn Lyles
Journal:  Neurotox Res       Date:  2007-04       Impact factor: 3.911

Review 9.  Dopamine receptors and Parkinson's disease.

Authors:  Shin Hisahara; Shun Shimohama
Journal:  Int J Med Chem       Date:  2011-06-13

10.  Targeting the progression of Parkinson's disease.

Authors:  J L George; S Mok; D Moses; S Wilkins; A I Bush; R A Cherny; D I Finkelstein
Journal:  Curr Neuropharmacol       Date:  2009-03       Impact factor: 7.363

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.